Clinical characteristics and treatment of pars planitis: an adalimumab experience


Özdemir H. B., Ozdal P. C.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, vol.260, no.2, pp.561-569, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 260 Issue: 2
  • Publication Date: 2022
  • Doi Number: 10.1007/s00417-021-05398-4
  • Journal Name: GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.561-569
  • Keywords: Pars planitis, Intermediate uveitis, Immunosuppressive treatment, Anti-tumour necrosis factor treatment, Adalimumab, NONINFECTIOUS UVEITIS, THERAPY, RETINOSCHISIS, MULTICENTER
  • Gazi University Affiliated: Yes

Abstract

Purpose This study aims to investigate the clinical and demographic characteristics, treatment outcomes and complications of patients with pars planitis.